BIOYF (Biosyent) Short Percentage of Float


BIOYF Biosyent Inc BIOYF
98 GF Score
Price $10.26
GF Value $11.25
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Biosyent Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

BIOYF vs ZTS, UTHR: Short Percentage of Float Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Biosyent's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biosyent Short Percentage of Float vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biosyent's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Biosyent's Short Percentage of Float falls into.


BIOYF
98GF Score
Biosyent Inc BIOYF
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Biosyent (BIOYF) Overvalued in 2026?

Based on GuruFocus' analysis, Biosyent stock appears to be undervalued. The current stock price of $10.26 is trading 8.8% below its estimated GF Value™ of $11.25. GuruFocus considers Biosyent to be Fairly Valued.

Key valuation signals for BIOYF:

  • Short Percentage of Float:
  • GF Value™: $11.25 vs. price of $10.26 (8.8% below fair value)
  • GF Score™: 98/100 with 4 warning signs

No single metric tells the full story. See the BIOYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Biosyent Business Description

Other Exchanges RX:Canada
Address 2476 Argentia Road, Suite 402, Mississauga, ON, CAN, L5N 6M1
Biosyent Inc is a Canada-based growth-oriented specialty pharmaceutical company. It markets and delivers a diverse range of healthcare products, including over-the-counter, behind-the-counter, and prescription options. It has focused on in-licensing or acquiring originative pharmaceuticals and other healthcare products. Its product includes FeraMAX Pd, Inofolic, Gelclair, Cathejell, RepaGyn, Proktis-M, and Tibella. The company derives revenue from pharmaceutical and insecticide business. Geographically, it derives maximum revenue from Canada and also has its presence internationally.
98GF Score

Get the complete analysis for BIOYF

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.26
Price
$11.25
GF Value